PharVision Advisers’s PepsiCo PEP Stock Holding History

PharVision Advisers’s Portfolio PEP Stock Details PEP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,612	Closed	-$213K	–	762
2025 Q2	$213K	Buy	+1,612	New	+$217K	0.31%	184
2025 Q1	–	Sell	-2,097	Closed	-$319K	–	459
2024 Q4	$319K	Buy	+2,097	New	+$344K	0.27%	131

Other funds holding PEP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PharVision Advisers's PEP Position: Q3 2025 in Review

PharVision Advisers sold out of PepsiCo (PEP) in Q3 2025, closing a stake of 1,612 shares — an estimated $213K sold.

PharVision Advisers first reported a position in PEP in Q4 2024 and held it in 2 quarters. The position peaked at $319K in Q4 2024. 3,311 funds tracked by Wall St. Rank hold PEP as of Q3 2025.

PharVision Advisers reported no remaining PepsiCo position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 1,612 PepsiCo shares in Q3 2025, an estimated $213K.
PharVision Advisers first reported a position in PepsiCo in Q4 2024 and held it in 2 quarters.
PharVision Advisers's PepsiCo position peaked at $319K in Q4 2024.
3,311 funds tracked by Wall St. Rank held PepsiCo as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.